Trial intelligence / Profile preview

Metformin versus myo-inositol + folic acid in women with polycystic ovary syndrome undergoing first IVF

IRCT20201219049758N1Phase 3Completed

Sponsor: Tehran University of Medical Sciences
Start: Oct 2018
Modality: Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries: 1

Overview

Phase 3, randomised, double-blind trial in polycystic ovary syndrome (PCOS) and infertility comparing Metformin control with Myo-inositol + folic acid intervention (2 arms). Primary endpoints: Body mass index, Ovum count and 9 more. Started Oct 2018; status: completed.

Drugs

metforminmyo-inositolfolic acid

Conditions

polycystic ovary syndrome (PCOS)infertility

Beyond the preview

Go deeper on IRCT20201219049758N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20201219049758N1.